Page 38 - ITPS-7-1

INNOSC Theranostics and
Pharmacological Sciences Antiplatelet treatments in neurological patients

events. In comparison, the SAC method is rather complex Continuum (Minneap Minn), 29: 584–604.
due to a lack of regulatory control over the migration and https://doi.org/10.1212/CON.0000000000001247
deposition of the coil. In conclusion, this review provides
details regarding various aneurysm treatments, and we 5. Hackenberg KAM, Etminan N, 2021, Neurovascular
believe a thorough understanding of these treatment disease, diagnosis, and therapy: Brain aneurysms. Handb
Clin Neurol, 176: 121–134.
methods could facilitate more personalized and monitored
care. https://doi.org/10.1016/B978-0-444-64034-5.00001-8
6. Gross BA, Du R, 2013, Natural history of cerebral
Acknowledgments arteriovenous malformations: A meta-analysis. J Neurosurg,
None. 118: 437–443.
https://doi.org/10.3171/2012.10.JNS121280
Funding
7. Pierot L, Wakhloo AK, 2013, Endovascular treatment of
None. intracranial aneurysms: Current status. Stroke, 44: 2046–
2054.
Conflict of interest
https://doi.org/10.1161/Strokeaha.113.000733
The authors declare no conflicts of interest. 8. Astrup J, Siesjö BK, Symon L, 1981, Thresholds in cerebral

Author contributions ischemia-the ischemic penumbra. Stroke, 12: 723–725.
https://doi.org/10.1161/01.str.12.6.723
Conceptualization: Brandon Lucke-Wold
Writing – original draft: Anjali Patel, Daisy Valle, Drashti 9. Shuaib A, Butcher K, Mohammad AA, et al., 2011, Collateral
Patel, Marco Foreman, Devon Foster, and Alexander blood vessels in acute ischaemic stroke: A potential
therapeutic target. Lancet Neurol, 10: 909–921.
Nguyen
Writing – review and editing: Anjali Patel https://doi.org/10.1016/S1474-4422(11)70195-8
10. Jackman K, Iadecola C, 2015, Neurovascular regulation in
Ethics approval and consent to participate the ischemic brain. Antioxid Redox Signal, 22: 149–160.
Not applicable. https://doi.org/10.1089/ars.2013.5669

Consent for publication 11. Weber R, Brenck J, Diener HC, 2012, Antiplatelet therapy
in cerebrovascular disorders. Handb Exp Pharmacol,
Not applicable. 210: 519–546.

Availability of data https://doi.org/10.1007/978-3-642-29423-5_21
12. Kamarova M, Baig S, Patel H, et al., 2022, Antiplatelet use in
Not applicable.
ischemic stroke. Ann Pharmacother, 56: 1159–1173.
References https://doi.org/10.1177/10600280211073009
1. Spiotta AM, Chaudry MI, Hui FK, et al., 2015, Evolution 13. Powers WJ, Rabinstein AA, Ackerson T, et al., 2019,
of thrombectomy approaches and devices for acute stroke: Guidelines for the early management of patients with acute
A technical review. J Neurointerv Surg, 7: 2–7. ischemic stroke: 2019 Update to the 2018 guidelines for the
early management of acute ischemic stroke: A guideline
https://doi.org/10.1136/neurintsurg-2013-011022
for healthcare professionals from the American heart
2. Spiotta AM, Hussain MS, Sivapatham T, et al., 2011, association/American stroke association. Stroke, 50:
The versatile distal access catheter: The Cleveland Clinic e344–e418.
experience. Neurosurgery, 68: 1677–1686.
https://doi.org/10.1161/STR.0000000000000211
https://doi.org/10.1227/NEU.0b013e31820edfd8
14. Alquwaizani M, Buckley L, Adams C, et al., 2013,
3. Turk A, Manzoor MU, Nyberg EM, et al, 2013, Initial Anticoagulants: A review of the pharmacology, dosing, and
experience with distal guide catheter placement in the complications. Curr Emerg Hosp Med Rep, 1: 83–97.
treatment of cerebrovascular disease: Clinical safety and https://doi.org/10.1007/s40138-013-0014-6
efficacy. J Neurointerv Surg, 5: 247–252.
15. Ross JA, Miller MM, Rojas Hernandez CMR, 2017,
https://doi.org/10.1136/neurintsurg-2011-010256
Comparative effectiveness and safety of direct
4. Nguyen TN, 2023, Management of unruptured intracranial oral anticoagulants (DOACs) versus conventional
aneurysms and brain arteriovenous malformations. anticoagulation for the treatment of cancer-related venous

Volume 7 Issue 1 (2024) 10 https://doi.org/10.36922/itps.1202